Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cecchini

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Pancreas|July 14, 2020
A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic CancerMichael Cecchini, Joseph A Miccio, Jay Pahade, et al.
JCO Oncology Practice|November 18, 2025
Accuracy of Computed Tomography Staging of Mismatch Repair-Deficient Colon CancerSamantha M Linhares, Thejal Srikumar, Clifford Shin, et al.
Cancer Research Communications|June 28, 2023
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid TumorsMichael Cecchini, Zenta Walther, Wei Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2019
Challenges with Novel Clinical Trial Designs: Master ProtocolsMichael Cecchini, Eric H Rubin, Gideon M Blumenthal, et al.
The Oncologist|October 14, 2024
Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutationsFaiza Yasin, Ethan Sokol, Neil Vasan, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
A single arm phase 2 clinical trial of YIV-906 with neoadjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancerNipun Verma, Kimberly L Johung, Jeremy Kortmansky, et al.
JCO Precision Oncology|February 19, 2026
PIK3CA Mutations in Early-Onset Appendiceal AdenocarcinomaPrincy Gupta, Rushabh Gujarathi, Lu Qiao, et al.
Journal of Gastrointestinal Oncology|July 12, 2023
Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancerGabrielle W Peters, Wesley Talcott, Nicholas V Peters, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Epigenomic Heterogeneity of Non-Functional Pancreatic Neuroendocrine Tumors Uncovered by Single nucleus and Spatial ATAC ProfilingDejiang Wang, Xiangjun Di, Fu Gao, et al.
American Journal of Clinical Oncology|November 1, 2022
Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas CancerMeriem Mokhtech, Joseph A Miccio, Kimberly Johung, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Pancreas|July 14, 2020
A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic CancerMichael Cecchini, Joseph A Miccio, Jay Pahade, et al.
JCO Oncology Practice|November 18, 2025
Accuracy of Computed Tomography Staging of Mismatch Repair-Deficient Colon CancerSamantha M Linhares, Thejal Srikumar, Clifford Shin, et al.
Cancer Research Communications|June 28, 2023
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid TumorsMichael Cecchini, Zenta Walther, Wei Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2019
Challenges with Novel Clinical Trial Designs: Master ProtocolsMichael Cecchini, Eric H Rubin, Gideon M Blumenthal, et al.
The Oncologist|October 14, 2024
Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutationsFaiza Yasin, Ethan Sokol, Neil Vasan, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
A single arm phase 2 clinical trial of YIV-906 with neoadjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancerNipun Verma, Kimberly L Johung, Jeremy Kortmansky, et al.
JCO Precision Oncology|February 19, 2026
PIK3CA Mutations in Early-Onset Appendiceal AdenocarcinomaPrincy Gupta, Rushabh Gujarathi, Lu Qiao, et al.
Journal of Gastrointestinal Oncology|July 12, 2023
Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancerGabrielle W Peters, Wesley Talcott, Nicholas V Peters, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Epigenomic Heterogeneity of Non-Functional Pancreatic Neuroendocrine Tumors Uncovered by Single nucleus and Spatial ATAC ProfilingDejiang Wang, Xiangjun Di, Fu Gao, et al.
American Journal of Clinical Oncology|November 1, 2022
Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas CancerMeriem Mokhtech, Joseph A Miccio, Kimberly Johung, et al.
Pageof 7